首页 > 最新文献

Current problems in cancer. Case reports最新文献

英文 中文
ML: Early Breast Cancer Diagnosis ML:早期乳腺癌诊断
Q4 ONCOLOGY Pub Date : 2024-01-09 DOI: 10.1016/j.cpccr.2024.100278
Seyed Matin Malakouti, Mohammad Bagher Menhaj, Amir Abolfazl Suratgar

Breast cancer is the most common malignancy among women worldwide, often characterized by the uncontrolled proliferation of breast cells, leading to the formation of lumps or tumors that can be detected through medical imaging such as X-rays. Distinguishing between benign and malignant tumors presents a significant challenge in the diagnosis of breast cancer.

In this study, machine learning methods, including Logistic Regression, Gradient Boosting, Ada Boost, Random Forest, and Gaussian NB with Grid Search, were employed to differentiate between healthy individuals and those with malignancies. The results revealed that the Random Forest algorithm exhibited the highest performance in predicting breast cancer, accurately identifying 99 % of both healthy and affected individuals. Additionally, both Gradient Boosting and Ada Boost demonstrated a similar level of accuracy, correctly distinguishing 98 % of healthy and affected individuals.

Conversely, Gaussian NB performed the least effectively, with an accuracy of 91 % in differentiating between healthy and affected individuals, highlighting its comparatively lower predictive capability for breast cancer.

乳腺癌是全球妇女中最常见的恶性肿瘤,其特征通常是乳腺细胞不受控制地增殖,从而形成肿块或肿瘤,这些肿块或肿瘤可通过 X 射线等医学影像检查出来。本研究采用了包括逻辑回归、梯度提升、Ada Boost、随机森林和网格搜索高斯 NB 在内的机器学习方法来区分健康人和恶性肿瘤患者。结果显示,随机森林算法在预测乳腺癌方面表现最佳,能准确识别 99% 的健康人和患病者。此外,梯度提升算法和 Ada Boost 算法也表现出了类似的准确率,能正确区分 98% 的健康人和患病者。相反,高斯 NB 算法的效果最差,在区分健康人和患病者方面的准确率仅为 91%,这突出表明该算法对乳腺癌的预测能力相对较低。
{"title":"ML: Early Breast Cancer Diagnosis","authors":"Seyed Matin Malakouti,&nbsp;Mohammad Bagher Menhaj,&nbsp;Amir Abolfazl Suratgar","doi":"10.1016/j.cpccr.2024.100278","DOIUrl":"https://doi.org/10.1016/j.cpccr.2024.100278","url":null,"abstract":"<div><p>Breast cancer is the most common malignancy among women worldwide, often characterized by the uncontrolled proliferation of breast cells, leading to the formation of lumps or tumors that can be detected through medical imaging such as X-rays. Distinguishing between benign and malignant tumors presents a significant challenge in the diagnosis of breast cancer.</p><p>In this study, machine learning methods, including Logistic Regression, Gradient Boosting, Ada Boost, Random Forest, and Gaussian NB with Grid Search, were employed to differentiate between healthy individuals and those with malignancies. The results revealed that the Random Forest algorithm exhibited the highest performance in predicting breast cancer, accurately identifying 99 % of both healthy and affected individuals. Additionally, both Gradient Boosting and Ada Boost demonstrated a similar level of accuracy, correctly distinguishing 98 % of healthy and affected individuals.</p><p>Conversely, Gaussian NB performed the least effectively, with an accuracy of 91 % in differentiating between healthy and affected individuals, highlighting its comparatively lower predictive capability for breast cancer.</p></div>","PeriodicalId":72741,"journal":{"name":"Current problems in cancer. Case reports","volume":"13 ","pages":"Article 100278"},"PeriodicalIF":0.0,"publicationDate":"2024-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666621924000012/pdfft?md5=ceb405394533ced110a3290c7dbc4ff6&pid=1-s2.0-S2666621924000012-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139436532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bilateral optic neuritis attributed to Pembrolizumab: A case report 彭博利珠单抗引发的双侧视神经炎:病例报告
Q4 ONCOLOGY Pub Date : 2024-01-06 DOI: 10.1016/j.cpccr.2023.100271
Dr Lucy G Faulkner , Dr Oyeyemi Akala , Dr Meera Chauhan , Dr Sean Dulloo

Immunotherapy has revolutionised cancer treatment over the past decade and is now well established in the management of a range of cancer primaries, including non-small cell lung cancer. Pembrolizumab acts as a checkpoint inhibitor through programmed death protein 1 (PD-1) inhibition. However, the use of immune checkpoint inhibitors can be complicated by immune-related adverse events (irAE). Neurological complications are rare but are associated with high morbidity compared to other irAE.

Here we report a rare case of bilateral optic neuritis following Pembrolizumab in a patient treated for metastatic lung adenocarcinoma. The patient had also received whole brain radiotherapy during the course of the treatment. Symptom onset occurred during maintenance treatment and at twelve months after first commencing systemic anticancer treatment. Fundoscopy demonstrated optic disc pallor with enhancement of the optic nerves and optic chiasm was seen on Magnetic Resonance Imaging. Symptoms were refractory to steroid treatment and resulted in chronic and profound visual impairment.

过去十年来,免疫疗法彻底改变了癌症治疗,目前已在包括非小细胞肺癌在内的一系列原发性癌症的治疗中得到广泛应用。Pembrolizumab 通过抑制程序性死亡蛋白 1 (PD-1) 发挥检查点抑制剂的作用。然而,免疫检查点抑制剂的使用可能会因免疫相关不良事件(irAE)而变得复杂。在这里,我们报告了一例罕见的双侧视神经炎病例,患者因转移性肺腺癌接受了 Pembrolizumab 治疗。患者在治疗期间还接受了全脑放疗。症状出现在维持治疗期间和首次开始全身抗癌治疗 12 个月后。眼底镜检查显示视盘苍白,视神经增强,磁共振成像显示有视交叉。这些症状对类固醇治疗无效,并导致长期和严重的视力损伤。
{"title":"Bilateral optic neuritis attributed to Pembrolizumab: A case report","authors":"Dr Lucy G Faulkner ,&nbsp;Dr Oyeyemi Akala ,&nbsp;Dr Meera Chauhan ,&nbsp;Dr Sean Dulloo","doi":"10.1016/j.cpccr.2023.100271","DOIUrl":"10.1016/j.cpccr.2023.100271","url":null,"abstract":"<div><p>Immunotherapy has revolutionised cancer treatment over the past decade and is now well established in the management of a range of cancer primaries, including non-small cell lung cancer. Pembrolizumab acts as a checkpoint inhibitor through programmed death protein 1 (PD-1) inhibition. However, the use of immune checkpoint inhibitors can be complicated by immune-related adverse events (irAE). Neurological complications are rare but are associated with high morbidity compared to other irAE.</p><p>Here we report a rare case of bilateral optic neuritis following Pembrolizumab in a patient treated for metastatic lung adenocarcinoma. The patient had also received whole brain radiotherapy during the course of the treatment. Symptom onset occurred during maintenance treatment and at twelve months after first commencing systemic anticancer treatment. Fundoscopy demonstrated optic disc pallor with enhancement of the optic nerves and optic chiasm was seen on Magnetic Resonance Imaging. Symptoms were refractory to steroid treatment and resulted in chronic and profound visual impairment.</p></div>","PeriodicalId":72741,"journal":{"name":"Current problems in cancer. Case reports","volume":"13 ","pages":"Article 100271"},"PeriodicalIF":0.0,"publicationDate":"2024-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666621923000558/pdfft?md5=0bd26457a6c5f96be440f1b57f7fa468&pid=1-s2.0-S2666621923000558-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139391957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Noninvasive prenatal testing detecting metastatic breast cancer: Case report and literature review 检测转移性乳腺癌的无创产前检测:病例报告和文献综述
Q4 ONCOLOGY Pub Date : 2024-01-01 DOI: 10.1016/j.cpccr.2023.100277
Gabriel Francisco Pereira Aleixo , Holly Pederson , Nancy Dalpiaz , Jame Abraham

Noninvasive prenatal testing (NIPT) analyzes placental cell-free DNA in maternal blood for genetic abnormalities, especially in pregnant women of advanced maternal age. It is a high-sensitivity and specificity test used for screening fetal chromosome trisomy 13, 18, 21, sex chromosome aneuploidy, and rare fetal chromosome aneuploidy. Rarely there were cases in which it was used to diagnose maternal cancer. We will discuss a case of metastatic breast cancer diagnosed by NIPT and current knowledge on the use of this technology in diagnosing cancer during pregnancy.

无创产前检测(NIPT)分析母体血液中胎盘无细胞 DNA 的遗传异常,尤其适用于高龄产妇。它是一种高灵敏度和特异性的检测方法,用于筛查胎儿染色体 13、18、21 三体综合征、性染色体非整倍体和罕见的胎儿染色体非整倍体。很少有病例用它来诊断母体癌症。我们将讨论一例通过 NIPT 诊断出的转移性乳腺癌病例,以及目前使用该技术诊断孕期癌症的相关知识。
{"title":"Noninvasive prenatal testing detecting metastatic breast cancer: Case report and literature review","authors":"Gabriel Francisco Pereira Aleixo ,&nbsp;Holly Pederson ,&nbsp;Nancy Dalpiaz ,&nbsp;Jame Abraham","doi":"10.1016/j.cpccr.2023.100277","DOIUrl":"10.1016/j.cpccr.2023.100277","url":null,"abstract":"<div><p>Noninvasive prenatal testing (NIPT) analyzes placental cell-free DNA in maternal blood for genetic abnormalities, especially in pregnant women of advanced maternal age. It is a high-sensitivity and specificity test used for screening fetal chromosome trisomy 13, 18, 21, sex chromosome aneuploidy, and rare fetal chromosome aneuploidy. Rarely there were cases in which it was used to diagnose maternal cancer. We will discuss a case of metastatic breast cancer diagnosed by NIPT and current knowledge on the use of this technology in diagnosing cancer during pregnancy.</p></div>","PeriodicalId":72741,"journal":{"name":"Current problems in cancer. Case reports","volume":"13 ","pages":"Article 100277"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666621923000613/pdfft?md5=7b55634122888285d9962acb319ddb46&pid=1-s2.0-S2666621923000613-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139127547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case report: Hypereosinophilia in non-small cell lung cancer 病例报告:非小细胞肺癌中的嗜酸性粒细胞增多症
Q4 ONCOLOGY Pub Date : 2024-01-01 DOI: 10.1016/j.cpccr.2023.100275
Hyunwoo Kwon , Mingjia Li , Jesse D Sheldon , Nicholas Jones , Nicolas Gallastegui Crestani , Zihai Li , Dwight H Owen

Background

Hypereosinophilia, as defined by the absolute eosinophil count ≥ 1,500 cells per microliter, can be a consequence of primary (clonal) hematologic disorders or secondary response to inflammation from allergens, parasitic infections, medications or cancer. Its evaluation requires comprehensive history and physical as well as laboratory studies to identify the underlying cause and assess for evidence of end-organ damage in concern for hypereosinophilia syndrome. Here, we report a rare case of paraneoplastic hypereosinophilia with an absolute eosinophil count exceeding 70,000 cells per microliter in the setting of a newly diagnosed metastatic non-small cell lung cancer.

Case presentation

A 60-year-old Caucasian male smoker with past medical history of cerebrovascular accidents and heart failure with reduced ejection fraction presented with acute encephalopathy and later developed multi-system organ failure. Peripheral blood smear and other hematologic studies were not suggestive of clonal hematologic malignancy. Extensive infectious work-up of peripheral blood, lower respiratory tract and cerebrospinal fluid was negative. Review of recent medical record did not identify any potentially causative drugs. Diagnostic thoracentesis of the loculated pleural effusion showed poorly differentiated non-small cell lung cancer, which was deemed as the underlying etiology of his profound hypereosinophilia. His encephalopathy and other signs and symptoms of end organ damage were thought less likely to be directly driven by hypereosinophilia. Progressive critical illness unfortunately precluded disease-directed therapy and his family opted for comfort care to mitigate suffering.

Conclusions

Our case report highlights paraneoplastic etiology as an important diagnostic consideration in a patient with unexplained hypereosinophilia. Review of the literature shows that hypereosinophilia in patients with non-small cell lung cancer and other solid malignancies correlates with rapid disease progression and poor prognosis, though the underlying mechanisms remain unclear. Interestingly, case reports of hypereosinophilia in non-small cell lung cancer suggest a male-biased incidence. Investigation of the role of eosinophils in modulating anti-tumor immunity and its sex difference is warranted.

背景嗜酸性粒细胞过多症的定义是嗜酸性粒细胞绝对计数≥1,500 个/微升,可能是原发性(克隆性)血液病的结果,也可能是过敏原、寄生虫感染、药物或癌症引起的炎症的继发反应。对该病的评估需要进行全面的病史、体格检查和实验室检查,以确定潜在的病因,并评估终末器官损伤的证据,以防出现嗜酸性粒细胞过多综合征。病例介绍 一位 60 岁的白种男性吸烟者,既往有脑血管意外和射血分数降低的心力衰竭病史,出现急性脑病,随后发展为多系统器官衰竭。外周血涂片和其他血液学检查未提示克隆性血液恶性肿瘤。外周血、下呼吸道和脑脊液的广泛感染检查结果均为阴性。查阅近期病历,未发现任何可能致病的药物。定位胸腔积液的诊断性胸腔穿刺术显示为分化较差的非小细胞肺癌,这被认为是其严重的高嗜酸性粒细胞增多症的根本病因。他的脑病和其他内脏器官损伤的症状和体征被认为不太可能是由嗜酸性粒细胞过多症直接引起的。我们的病例报告强调了副肿瘤病因是不明原因的高嗜酸性粒细胞增多症患者的一个重要诊断考虑因素。文献综述显示,非小细胞肺癌和其他实体恶性肿瘤患者的嗜酸性粒细胞增多症与疾病进展迅速和预后不良有关,但其潜在机制仍不清楚。有趣的是,非小细胞肺癌患者嗜酸性粒细胞过多的病例报告表明,其发病率偏向男性。有必要对嗜酸性粒细胞在调节抗肿瘤免疫中的作用及其性别差异进行研究。
{"title":"Case report: Hypereosinophilia in non-small cell lung cancer","authors":"Hyunwoo Kwon ,&nbsp;Mingjia Li ,&nbsp;Jesse D Sheldon ,&nbsp;Nicholas Jones ,&nbsp;Nicolas Gallastegui Crestani ,&nbsp;Zihai Li ,&nbsp;Dwight H Owen","doi":"10.1016/j.cpccr.2023.100275","DOIUrl":"https://doi.org/10.1016/j.cpccr.2023.100275","url":null,"abstract":"<div><h3>Background</h3><p>Hypereosinophilia, as defined by the absolute eosinophil count ≥ 1,500 cells per microliter, can be a consequence of primary (clonal) hematologic disorders or secondary response to inflammation from allergens, parasitic infections, medications or cancer. Its evaluation requires comprehensive history and physical as well as laboratory studies to identify the underlying cause and assess for evidence of end-organ damage in concern for hypereosinophilia syndrome. Here, we report a rare case of paraneoplastic hypereosinophilia with an absolute eosinophil count exceeding 70,000 cells per microliter in the setting of a newly diagnosed metastatic non-small cell lung cancer.</p></div><div><h3>Case presentation</h3><p>A 60-year-old Caucasian male smoker with past medical history of cerebrovascular accidents and heart failure with reduced ejection fraction presented with acute encephalopathy and later developed multi-system organ failure. Peripheral blood smear and other hematologic studies were not suggestive of clonal hematologic malignancy. Extensive infectious work-up of peripheral blood, lower respiratory tract and cerebrospinal fluid was negative. Review of recent medical record did not identify any potentially causative drugs. Diagnostic thoracentesis of the loculated pleural effusion showed poorly differentiated non-small cell lung cancer, which was deemed as the underlying etiology of his profound hypereosinophilia. His encephalopathy and other signs and symptoms of end organ damage were thought less likely to be directly driven by hypereosinophilia. Progressive critical illness unfortunately precluded disease-directed therapy and his family opted for comfort care to mitigate suffering.</p></div><div><h3>Conclusions</h3><p>Our case report highlights paraneoplastic etiology as an important diagnostic consideration in a patient with unexplained hypereosinophilia. Review of the literature shows that hypereosinophilia in patients with non-small cell lung cancer and other solid malignancies correlates with rapid disease progression and poor prognosis, though the underlying mechanisms remain unclear. Interestingly, case reports of hypereosinophilia in non-small cell lung cancer suggest a male-biased incidence. Investigation of the role of eosinophils in modulating anti-tumor immunity and its sex difference is warranted.</p></div>","PeriodicalId":72741,"journal":{"name":"Current problems in cancer. Case reports","volume":"13 ","pages":"Article 100275"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666621923000595/pdfft?md5=9a5b3dcd9a8d27eeae1abba47671966e&pid=1-s2.0-S2666621923000595-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139100331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bilateral orbital metastases from lobular breast carcinoma mimicking an orbital inflammatory process 模仿眼眶炎症过程的小叶乳腺癌双侧眼眶转移瘤
Q4 ONCOLOGY Pub Date : 2023-12-27 DOI: 10.1016/j.cpccr.2023.100274
Matteo Mario Carlà , Luca Ausili Cefaro , Gianluca Di Fiore , Giovanni Cuffaro , Carola Culiersi , Teresa Musarra , Gustavo Savino

We report a case of synchronous bilateral orbital metastases from primary lobular breast cancer with the radiographic imaging features of a diffuse orbital soft tissue inflammatory process. A 77-year-old lady with a history of lobular breast cancer and bilateral quadrantectomy 15 years earlier was referred to our Ocular Oncology Unit. She complained about double vision and ocular pain. Through an ophthalmological examination, she presented significant bilateral proptosis and complete ophthalmoplegia. Magnetic resonance imaging showed a diffuse soft tissue infiltration of both orbits with mild T2w fat-sat hyperintensity and T1-isointensity relative to extra-ocular muscles and a diffuse involvement of both the intra- and extra-conal compartments. Significant enlargement of the extraocular muscles without sparing the muscle tendons and eyelids soft tissue swelling were also evident. Post-contrast images showed a diffuse and bilateral contrast enhancement of the involved tissues. Due to the inconclusive imaging findings, a bilateral orbital incisional biopsy was planned. The histopathological and immunohistochemical diagnosis was of lobular breast carcinoma and the patient underwent external beam radiotherapy with consistent clinical improvement. In conclusion, post-menopausal women presenting with a history of breast carcinoma and clinical and radiographic findings suggestive of acute bilateral orbital inflammatory disease should be biopsied to rule out metastatic disease even several years from the primary tumour.

我们报告了一例原发性小叶乳腺癌双侧眼眶同步转移病例,其放射影像学特征为弥漫性眼眶软组织炎症过程。一位 77 岁的女士被转诊到我们的眼肿瘤科,她在 15 年前曾患乳腺小叶癌并接受了双侧四肢切除术。她主诉复视和眼部疼痛。通过眼科检查,她出现了明显的双侧突眼和完全性眼瘫。磁共振成像显示双侧眼眶弥漫性软组织浸润,相对于眼外肌有轻度的T2w脂肪Sat高密度和T1异密度,眼眶内和眼眶外均弥漫性受累。眼外肌明显肿大,但肌腱和眼睑软组织肿胀未受影响。对比后图像显示,受累组织呈弥漫性双侧对比增强。由于影像学结果不确定,医生计划进行双侧眼眶切开活检。组织病理学和免疫组化诊断为乳腺小叶癌,患者接受了体外放射治疗,临床症状持续改善。总之,绝经后妇女如果有乳腺癌病史,且临床和影像学检查结果提示急性双侧眼眶炎症性疾病,即使距离原发肿瘤已有数年,也应进行活检以排除转移性疾病。
{"title":"Bilateral orbital metastases from lobular breast carcinoma mimicking an orbital inflammatory process","authors":"Matteo Mario Carlà ,&nbsp;Luca Ausili Cefaro ,&nbsp;Gianluca Di Fiore ,&nbsp;Giovanni Cuffaro ,&nbsp;Carola Culiersi ,&nbsp;Teresa Musarra ,&nbsp;Gustavo Savino","doi":"10.1016/j.cpccr.2023.100274","DOIUrl":"https://doi.org/10.1016/j.cpccr.2023.100274","url":null,"abstract":"<div><p>We report a case of synchronous bilateral orbital metastases from primary lobular breast cancer with the radiographic imaging features of a diffuse orbital soft tissue inflammatory process. A 77-year-old lady with a history of lobular breast cancer and bilateral quadrantectomy 15 years earlier was referred to our Ocular Oncology Unit. She complained about double vision and ocular pain. Through an ophthalmological examination, she presented significant bilateral proptosis and complete ophthalmoplegia. Magnetic resonance imaging showed a diffuse soft tissue infiltration of both orbits with mild T2w fat-sat hyperintensity and T1-isointensity relative to extra-ocular muscles and a diffuse involvement of both the intra- and extra-conal compartments. Significant enlargement of the extraocular muscles without sparing the muscle tendons and eyelids soft tissue swelling were also evident. Post-contrast images showed a diffuse and bilateral contrast enhancement of the involved tissues. Due to the inconclusive imaging findings, a bilateral orbital incisional biopsy was planned. The histopathological and immunohistochemical diagnosis was of lobular breast carcinoma and the patient underwent external beam radiotherapy with consistent clinical improvement. In conclusion, post-menopausal women presenting with a history of breast carcinoma and clinical and radiographic findings suggestive of acute bilateral orbital inflammatory disease should be biopsied to rule out metastatic disease even several years from the primary tumour.</p></div>","PeriodicalId":72741,"journal":{"name":"Current problems in cancer. Case reports","volume":"13 ","pages":"Article 100274"},"PeriodicalIF":0.0,"publicationDate":"2023-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666621923000583/pdfft?md5=d0079c5eaacddc1efa9c4aab4981ebfb&pid=1-s2.0-S2666621923000583-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139433397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Secondary monoclonal gammopathy of unknown significance with isotype switching after CAR T-cell therapy for multiple myeloma: A case report 多发性骨髓瘤 CAR T 细胞疗法后出现同型转换的继发性单克隆抗体病(意义不明):病例报告
Q4 ONCOLOGY Pub Date : 2023-12-23 DOI: 10.1016/j.cpccr.2023.100276
Nilesh M. Kalariya , Hans C. Lee , Muzaffar H. Qazilbash , Krina K. Patel

The incidence of secondary monoclonal gammopathy of undetermined significance is limited in patients with multiple myeloma post chimeric antigen receptor T-cell therapy. This is a case of secondary monoclonal gammopathy of undetermined significance with the appearance of distinct paraprotein peaks demonstrating isotype switching from IgA lambda to IgG lambda within 6 months post autologous chimeric antigen receptor T-cell therapy in a 66 year old multiple myeloma patient. Secondary monoclonal gammopathy of undetermined significance with or without isotype switching and/or new paraprotein bands may be a rare but important example of a benign and transient phenomenon representing pseudo-disease progression and potentially associated with longer progression-free survival and better overall outcomes. Although such association remains speculative given paucity of literature and an absence of high-quality data.

在接受嵌合抗原受体T细胞治疗后的多发性骨髓瘤患者中,意义不明的继发性单克隆丙种球蛋白病的发病率很低。本病例是一名66岁的多发性骨髓瘤患者在接受自体嵌合抗原受体T细胞治疗后6个月内出现的意义未定的继发性单克隆丙种球蛋白病,并伴有明显的副蛋白峰,显示同种型从IgA lambda转换为IgG lambda。意义未定的继发性单克隆丙种球蛋白病(无论有无同型转换和/或新的副蛋白条带)可能是一种罕见但重要的良性和短暂现象,代表着假性疾病进展,可能与更长的无进展生存期和更好的总体预后有关。尽管由于文献资料较少且缺乏高质量的数据,这种关联仍是推测性的。
{"title":"Secondary monoclonal gammopathy of unknown significance with isotype switching after CAR T-cell therapy for multiple myeloma: A case report","authors":"Nilesh M. Kalariya ,&nbsp;Hans C. Lee ,&nbsp;Muzaffar H. Qazilbash ,&nbsp;Krina K. Patel","doi":"10.1016/j.cpccr.2023.100276","DOIUrl":"https://doi.org/10.1016/j.cpccr.2023.100276","url":null,"abstract":"<div><p>The incidence of secondary monoclonal gammopathy of undetermined significance is limited in patients with multiple myeloma post chimeric antigen receptor T-cell therapy. This is a case of secondary monoclonal gammopathy of undetermined significance with the appearance of distinct paraprotein peaks demonstrating isotype switching from IgA lambda to IgG lambda within 6 months post autologous chimeric antigen receptor T-cell therapy in a 66 year old multiple myeloma patient. Secondary monoclonal gammopathy of undetermined significance with or without isotype switching and/or new paraprotein bands may be a rare but important example of a benign and transient phenomenon representing pseudo-disease progression and potentially associated with longer progression-free survival and better overall outcomes. Although such association remains speculative given paucity of literature and an absence of high-quality data.</p></div>","PeriodicalId":72741,"journal":{"name":"Current problems in cancer. Case reports","volume":"13 ","pages":"Article 100276"},"PeriodicalIF":0.0,"publicationDate":"2023-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666621923000601/pdfft?md5=a15444bc0eb25f6d79f7dce78008bc4a&pid=1-s2.0-S2666621923000601-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139100329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unusual presentation and course of malignant melanoma of anal canal in an African-American patient 一名非裔美国人肛管恶性黑色素瘤的异常表现和病程
Q4 ONCOLOGY Pub Date : 2023-12-23 DOI: 10.1016/j.cpccr.2023.100272
Mediha Siddiqui , Joe Saad , Darshan Gandhi

Background

While cutaneous melanoma is common in up to 2.6% of Caucasian population, it is far less common in the African American population, up to 0.1%. Additionally, anal melanoma in particular comprises less than 1% of all melanomas and roughly 4% of anal cancers, while Spindle-cell variants are even less common, suggesting an extremely low incidence in the African American population. Definitive diagnosis can be challenging due to lack of definitive mass or pigmentation at presentation. There is a lack of good long-term studies and treatment guidelines for this malignancy with significant variation in treatment approaches and patient outcomes.

Case description

Here we present a case of an 63-year old African American gentleman with no significant past medical history and unremarkable colonoscopy 3 years prior, who presented with a mass in the anal canal that was found during a scheduled screening colonoscopy. The patient was completely asymptomatic at presentation. PET/CT scan showed hypermetabolic activity in the anal canal region. Patient underwent surgical excision with pathology revealing a 2.7 cm spindle cell type of malignant melanoma and promptly treated with adjuvant immunotherapy, resulting in extended progression-free survival before recurrence in the liver.

Conclusion

The early diagnosis of spindle cell melanoma can prompt more aggressive surgical and systemic management options resulting in extended survival, however, late recurrences are common and often refractory to standard therapeutic options.

背景皮肤黑色素瘤在白种人中的发病率高达 2.6%,但在非裔美国人中的发病率却低得多,仅为 0.1%。此外,肛门黑色素瘤在所有黑色素瘤中的发病率不到 1%,在肛门癌中约占 4%,而纺锤形细胞变异型黑色素瘤的发病率则更低,这表明黑色素瘤在非裔美国人中的发病率极低。由于发病时没有明确的肿块或色素沉着,明确诊断可能具有挑战性。我们在此介绍一例 63 岁的非裔美国人病例,该患者既往无重大病史,3 年前结肠镜检查无异常,在一次预定的结肠镜筛查中发现肛管内有肿块。患者就诊时完全没有症状。PET/CT 扫描显示肛管区域存在高代谢活动。患者接受了手术切除,病理显示为 2.7 厘米的纺锤形细胞型恶性黑色素瘤,并及时接受了辅助免疫治疗,结果在肝脏复发前延长了无进展生存期。
{"title":"Unusual presentation and course of malignant melanoma of anal canal in an African-American patient","authors":"Mediha Siddiqui ,&nbsp;Joe Saad ,&nbsp;Darshan Gandhi","doi":"10.1016/j.cpccr.2023.100272","DOIUrl":"https://doi.org/10.1016/j.cpccr.2023.100272","url":null,"abstract":"<div><h3>Background</h3><p>While cutaneous melanoma is common in up to 2.6% of Caucasian population, it is far less common in the African American population, up to 0.1%. Additionally, anal melanoma in particular comprises less than 1% of all melanomas and roughly 4% of anal cancers, while Spindle-cell variants are even less common, suggesting an extremely low incidence in the African American population. Definitive diagnosis can be challenging due to lack of definitive mass or pigmentation at presentation. There is a lack of good long-term studies and treatment guidelines for this malignancy with significant variation in treatment approaches and patient outcomes.</p></div><div><h3>Case description</h3><p>Here we present a case of an 63-year old African American gentleman with no significant past medical history and unremarkable colonoscopy 3 years prior, who presented with a mass in the anal canal that was found during a scheduled screening colonoscopy. The patient was completely asymptomatic at presentation. PET/CT scan showed hypermetabolic activity in the anal canal region. Patient underwent surgical excision with pathology revealing a 2.7 cm spindle cell type of malignant melanoma and promptly treated with adjuvant immunotherapy, resulting in extended progression-free survival before recurrence in the liver.</p></div><div><h3>Conclusion</h3><p>The early diagnosis of spindle cell melanoma can prompt more aggressive surgical and systemic management options resulting in extended survival, however, late recurrences are common and often refractory to standard therapeutic options.</p></div>","PeriodicalId":72741,"journal":{"name":"Current problems in cancer. Case reports","volume":"13 ","pages":"Article 100272"},"PeriodicalIF":0.0,"publicationDate":"2023-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S266662192300056X/pdfft?md5=55e893ff3c002a68c961475ac0733f89&pid=1-s2.0-S266662192300056X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139100330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe scalp ulcerations and granulomata during treatment with amivantamab 阿米万他单抗治疗期间的严重头皮溃疡和肉芽肿
Q4 ONCOLOGY Pub Date : 2023-12-20 DOI: 10.1016/j.cpccr.2023.100273
Jingjia J Zhou , Lanyi N Chen , Thomas Lehan , Benjamin Herzberg , Brian S Henick , Michael Pitman , Stephanie Gallitano , Catherine A Shu

This case series of 9 patients with NSCLC is the first to detail the presentation and treatment of ulcerative scalp lesions associated with amivantamab, a bispecific antibody which targets both epithelial growth factor receptor (EGFR) and mesenchymal-epithelial transition factor (MET). At our institution, 33 % of all patients on amivantamab develop scalp ulcerations, following a classic presentation of papulopustular eruption of the face and trunk (9/9), paronychia (9/9), and oral mucositis (7/9). The scalp lesions began as follicular pustules, progressing to vegetative ulcerative plaques within 23 weeks. Ulcerations were refractory to treatment despite trials of multiple systemic therapies, including prednisone, acitretin, cyclosporine, secukinumab, and oral antibiotics. Prednisone offered the most substantial benefit while topical wound care including dressings and washes such as ketoconazole proprionate, sodium sulfacetamide & sulfur soap, salicylic acid shampoo, and Coloplast®/Duoderm®/Aquacel® dressings provided symptomatic relief. One patient also developed granulomas on her vocal cords. More research on treatment and prevention is needed, as 6/9 patients stopped amivantamab due to their skin toxicities. Meanwhile, oncologists and dermatologists must collaborate to monitor toxicities, prepare patients for the possibility of scalp ulcerations, and provide symptomatic relief whenever possible.

阿米万他单抗是一种同时针对上皮细胞生长因子受体(EGFR)和间充质-上皮细胞转化因子(MET)的双特异性抗体,本系列病例首次详细介绍了9例NSCLC患者头皮溃疡性病变的表现和治疗方法。在我院,服用阿米万他单抗的患者中有 33% 出现头皮溃疡,其典型表现为面部和躯干丘疹脓疱疹(9/9)、脓疱疮(9/9)和口腔黏膜炎(7/9)。头皮皮损最初为毛囊性脓疱,23周内发展为植物性溃疡斑块。尽管试用了多种系统疗法,包括泼尼松、阿曲汀、环孢素、secukinumab和口服抗生素,但溃疡仍难治。泼尼松的疗效最为显著,而局部伤口护理,包括敷料和清洗剂(如酮康唑原液、磺胺醋酰胺钠&;硫磺皂、水杨酸洗发水和Coloplast®/Duoderm®/Aquacel®敷料)则可缓解症状。一名患者的声带也出现了肉芽肿。由于 6/9 名患者因皮肤毒性而停止使用阿米万他单抗,因此需要对治疗和预防进行更多研究。同时,肿瘤科医生和皮肤科医生必须合作监测毒性反应,让患者对头皮溃疡的可能性做好准备,并尽可能缓解症状。
{"title":"Severe scalp ulcerations and granulomata during treatment with amivantamab","authors":"Jingjia J Zhou ,&nbsp;Lanyi N Chen ,&nbsp;Thomas Lehan ,&nbsp;Benjamin Herzberg ,&nbsp;Brian S Henick ,&nbsp;Michael Pitman ,&nbsp;Stephanie Gallitano ,&nbsp;Catherine A Shu","doi":"10.1016/j.cpccr.2023.100273","DOIUrl":"10.1016/j.cpccr.2023.100273","url":null,"abstract":"<div><p>This case series of 9 patients with NSCLC is the first to detail the presentation and treatment of ulcerative scalp lesions associated with amivantamab, a bispecific antibody which targets both epithelial growth factor receptor (<em>EGFR</em>) and mesenchymal-epithelial transition factor (<em>MET</em>). At our institution, 33 % of all patients on amivantamab develop scalp ulcerations, following a classic presentation of papulopustular eruption of the face and trunk (9/9), paronychia (9/9), and oral mucositis (7/9). The scalp lesions began as follicular pustules, progressing to vegetative ulcerative plaques within 23 weeks. Ulcerations were refractory to treatment despite trials of multiple systemic therapies, including prednisone, acitretin, cyclosporine, secukinumab, and oral antibiotics. Prednisone offered the most substantial benefit while topical wound care including dressings and washes such as ketoconazole proprionate, sodium sulfacetamide &amp; sulfur soap, salicylic acid shampoo, and Coloplast®/Duoderm®/Aquacel® dressings provided symptomatic relief. One patient also developed granulomas on her vocal cords. More research on treatment and prevention is needed, as 6/9 patients stopped amivantamab due to their skin toxicities. Meanwhile, oncologists and dermatologists must collaborate to monitor toxicities, prepare patients for the possibility of scalp ulcerations, and provide symptomatic relief whenever possible.</p></div>","PeriodicalId":72741,"journal":{"name":"Current problems in cancer. Case reports","volume":"13 ","pages":"Article 100273"},"PeriodicalIF":0.0,"publicationDate":"2023-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666621923000571/pdfft?md5=553ab606a6b116456bb368804ab27352&pid=1-s2.0-S2666621923000571-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139191752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low-grade B-cell lymphomas in the spinal epidural space: A case series and review of the literature 脊髓硬膜外腔低级别b细胞淋巴瘤:病例系列及文献回顾
Q4 ONCOLOGY Pub Date : 2023-12-01 DOI: 10.1016/j.cpccr.2023.100269
Sandra Leskinen , Hamza Khilji , Faina Ablyazova , Avraham Zlochower , Manju Harshan , A. Gabriella Wernicke , Morana Vojnic , Randy S. D'Amico

Lymphoma rarely arises within the central nervous system and occurs most commonly in association with disseminated systemic disease. Primary epidural lymphomas of the spine are infrequently encountered and are usually high-grade, diffuse large B-cell lymphomas. Low-grade lymphomas arising in the spine are rarer than high-grades and are usually marginal zone lymphomas. While treatments for systemic high-grade lymphomas are well defined, treatment of low-grade lymphomas arising within the Dura or within the epidural space are less defined. We present two cases of primary spinal Dural- and epidural-based low-grade lymphomas diagnosed surgically and treated with local adjuvant radiation without chemotherapy. Both patients demonstrated excellent long term symptomatic and systemic disease control. We review the literature on epidural and Dural low-grade lymphomas to guide treatment of these rare lesions.

淋巴瘤很少发生在中枢神经系统,最常见于弥散性全身性疾病。原发性脊柱硬膜外淋巴瘤并不常见,通常为高级别弥漫性大b细胞淋巴瘤。发生在脊柱的低级别淋巴瘤比高级别淋巴瘤罕见,通常为边缘区淋巴瘤。虽然对全身性高级别淋巴瘤的治疗有明确的定义,但对发生在硬脑膜内或硬膜外腔内的低级别淋巴瘤的治疗却没有明确的定义。我们报告两例以硬脊膜和硬脊膜外为基础的原发性低级别淋巴瘤,经手术诊断并接受局部辅助放疗而不进行化疗。两例患者均表现出良好的长期症状和全身性疾病控制。我们回顾有关硬膜外和硬膜外低级别淋巴瘤的文献,以指导这些罕见病变的治疗。
{"title":"Low-grade B-cell lymphomas in the spinal epidural space: A case series and review of the literature","authors":"Sandra Leskinen ,&nbsp;Hamza Khilji ,&nbsp;Faina Ablyazova ,&nbsp;Avraham Zlochower ,&nbsp;Manju Harshan ,&nbsp;A. Gabriella Wernicke ,&nbsp;Morana Vojnic ,&nbsp;Randy S. D'Amico","doi":"10.1016/j.cpccr.2023.100269","DOIUrl":"https://doi.org/10.1016/j.cpccr.2023.100269","url":null,"abstract":"<div><p>Lymphoma rarely arises within the central nervous system and occurs most commonly in association with disseminated systemic disease. Primary epidural lymphomas of the spine are infrequently encountered and are usually high-grade, diffuse large B-cell lymphomas. Low-grade lymphomas arising in the spine are rarer than high-grades and are usually marginal zone lymphomas. While treatments for systemic high-grade lymphomas are well defined, treatment of low-grade lymphomas arising within the Dura or within the epidural space are less defined. We present two cases of primary spinal Dural- and epidural-based low-grade lymphomas diagnosed surgically and treated with local adjuvant radiation without chemotherapy. Both patients demonstrated excellent long term symptomatic and systemic disease control. We review the literature on epidural and Dural low-grade lymphomas to guide treatment of these rare lesions.</p></div>","PeriodicalId":72741,"journal":{"name":"Current problems in cancer. Case reports","volume":"12 ","pages":"Article 100269"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666621923000534/pdfft?md5=8656c2390c3940dba470d65f9116121a&pid=1-s2.0-S2666621923000534-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138501300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reduced-dose carmustine (300 mg/m2) and melphalan as a conditioning regimen in multiple myeloma patients with CNS involvement: A case series 减少剂量卡莫汀(300mg /m2)和美伐兰作为中枢神经系统受累多发性骨髓瘤患者的调节方案:一个病例系列
Q4 ONCOLOGY Pub Date : 2023-12-01 DOI: 10.1016/j.cpccr.2023.100270
Garrett Rueda , Eric Smith , Nicolas De Padova , Hayley Heers , Ivan Komerdelj

Single-agent melphalan remains the gold standard for conditioning chemotherapy prior to autologous stem cell transplantation (ASCT) in the multiple myeloma (MM) setting. Melphalan's distribution in the central nervous system (CNS) is limited which raises the question if single-agent melphalan is the ideal conditioning regimen for MM patients with extramedullary involvement in the CNS. Here we present two patients with MM and CNS involvement at baseline who safely received reduced-dose carmustine (300 mg/m2) and melphalan for conditioning chemotherapy prior to ASCT. While this combination has been studied previously, no studies to our knowledge added carmustine to the preparative regimen explicitly for additive CNS penetration in patients with CNS involvement.

单药美法兰仍然是多发性骨髓瘤(MM)自体干细胞移植(ASCT)前调理化疗的金标准。Melphalan在中枢神经系统(CNS)的分布是有限的,这就提出了一个问题:对于髓外受累的MM患者,单药Melphalan是否是理想的调节方案?在此,我们报告了两例基线时MM和CNS受累的患者,他们在ASCT前安全接受了减少剂量的卡莫司汀(300 mg/m2)和美法兰的调节化疗。虽然之前已经研究过这种组合,但据我们所知,没有研究明确地将卡莫司汀添加到预备方案中,以增加对中枢神经系统受累患者的中枢神经系统渗透。
{"title":"Reduced-dose carmustine (300 mg/m2) and melphalan as a conditioning regimen in multiple myeloma patients with CNS involvement: A case series","authors":"Garrett Rueda ,&nbsp;Eric Smith ,&nbsp;Nicolas De Padova ,&nbsp;Hayley Heers ,&nbsp;Ivan Komerdelj","doi":"10.1016/j.cpccr.2023.100270","DOIUrl":"https://doi.org/10.1016/j.cpccr.2023.100270","url":null,"abstract":"<div><p>Single-agent melphalan remains the gold standard for conditioning chemotherapy prior to autologous stem cell transplantation (ASCT) in the multiple myeloma (MM) setting. Melphalan's distribution in the central nervous system (CNS) is limited which raises the question if single-agent melphalan is the ideal conditioning regimen for MM patients with extramedullary involvement in the CNS. Here we present two patients with MM and CNS involvement at baseline who safely received reduced-dose carmustine (300 mg/m<sup>2</sup>) and melphalan for conditioning chemotherapy prior to ASCT. While this combination has been studied previously, no studies to our knowledge added carmustine to the preparative regimen explicitly for additive CNS penetration in patients with CNS involvement.</p></div>","PeriodicalId":72741,"journal":{"name":"Current problems in cancer. Case reports","volume":"12 ","pages":"Article 100270"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666621923000546/pdfft?md5=317ba326557f4aeefc515088e49dcaab&pid=1-s2.0-S2666621923000546-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138480408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current problems in cancer. Case reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1